HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Toxoid Vaccines

Neutralizing the effects of bacterial toxins, toxoid vaccines provide targeted protection against toxin-mediated diseases such as tetanus and diphtheria. Created by inactivating toxins while preserving their immunogenic structure, these vaccines train the immune system to block toxin action upon exposure. With well-established safety records and effectiveness, toxoid formulations continue to be a staple in routine immunization schedules. Recent developments have focused on optimizing immune response through improved formulation techniques and strategic antigen combinations. Researchers are also working to broaden the scope of protection to cover additional toxin-producing bacteria and extend the duration of immunity. As preventable diseases remain a concern in underserved regions, toxoid vaccines continue to play a critical role in public health.

Committee Members
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
IVC 2025 Speakers
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
Speaker at International Vaccines Congress 2025 - Lara Isis Teodoro

Lara Isis Teodoro

Mayo Clinic, United States
Speaker at International Vaccines Congress 2025 - Ahmed Abdulazeez

Ahmed Abdulazeez

BHRUT Trust, United Kingdom
Speaker at International Vaccines Congress 2025 - Elena Chiappini

Elena Chiappini

University of Florence, Italy

Submit your abstract Today

Watsapp